WhiteHawk joins forces with Tesserent to help SMBs prevent cyber crime

|

Published 15-MAR-2018 12:23 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Junior tech play, Whitehawk (ASX:WHK) has revealed its new partnership with Tesserent (ASX:TNT), a leading Australian provider of cyber-security products and services.

This collaboration will see TNT’s enterprise-grade cyber-security solution for SMBs, CyberBiz, offered through the WhiteHawk exchange. Here, SMB buyers can seek advice relating to their cyber-security needs and be matched to vendor products based on their risk profile.

TNT is a specialist in managed cyber-security. It manages direct end-customers in Australia while also offering a managed security service to wholesale channel partners globally, enabling them to deliver effective cyber-security management to their end customers.

This makes it a perfect partner for WHK, whose offers online marketplace is a one-stop portal for small and medium-sized companies to access tools for cyber-security.

TNT’s CyberBiz solution is a managed security service specifically designed for SMBs, giving them the same level of cyber-security as large organisations on more affordable terms.

While there are many cyber-security offerings available to SMBs, most require business owners to install and manage the equipment themselves. Under the CyberBiz managed service model, however, TNT monitors and protects its customers’ network, thereby letting them to focus on actually growing their businesses.

“CyberBiz enables small and mid-sized business owners to rest easy, knowing that our team of security engineers are looking after their network security,” said TNT head of sales and marketing, Karen Negus. “The WhiteHawk exchange is a great way for businesses of all sizes to obtain assistance with their cyber security needs.”

Negus continued: “We’re thrilled that the WhiteHawk team understand the immense value CyberBiz can offer SMB customers, and we’re looking forward to partnering with WhiteHawk to drive awareness and adoption of robust cybersecurity solutions within the SMB market.”

WHK CEO, Terry Roberts, said: “Establishing a strategic partnership with Tesserent is a no-brainer for us because it’s been so difficult to find quality cyber-security vendors with effective, easy to purchase, and affordable options for small and medium size businesses.

“We are delighted to bring the CyberBiz solution to the world via our platform which will enable SMBs to help protect their digital assets and prevent online crime and fraud,” Roberts said.

Tesserent’s CyberBiz solution is now available on the WhiteHawk exchange, joining more than 200 vendors and over 500 unique products and services.

Of course, it should be noted here that WHK is still in its early stages and anything can happen, so investors should seek professional financial advice if considering this stock for their portfolio.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X